Life Science Companies are Litigation Targets for Unhappy Investors Post author:Sam Post published:February 22, 2018 Post category:BioPharma Life science companies are popular targets for securities fraud litigation. Source: BioSpace You Might Also Like Massive FDA and NIH Cuts in Outlined Budget Plan May 22, 2017 Perrigo Shakes Up Exec Roster and Board, Hands Out a Fistful of Pink Slips April 16, 2017 Bay Area's OncoMed Tanks Some More as GlaxoSmithKline Walks Away From R&D Pact July 10, 2017
